IPCI’s generic Folcalin needs more bio-equivalence testing before final FDA approval: http://finance.yahoo.com/news/intellipharmaceutics-updates-status-tentative-approvals-213043966.html If it were up to me, there would be more PRs like this one (#msg-114661837).